It has been reported that the reduction in serum levels of tumor necrosis factor alpha (TNF-α) following systemic chemotherapy in lymphoproliferative malignancies (leukemia and lymphoma) in patients is linked with response rates [146,147]. Here, TNF is linked to leukemia.